COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection

COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection

Effect of Covid-19 disease in clotting factors levels in hospitalized patients

Effect of Covid-19 disease in clotting factors levels in hospitalized patients positive for sars-cov2 infection.

Association between clotting factors levels and disease severity,morbidity and mortality in these patients.

Effect of anticoagulant therapy in the clotting factors' levels in these patients

Inclusion Criteria:

• AGE> 18
• SINGED INFORMED CONSENT FORM
• POSITIVE PCR TEST FOR SARS-COV2 INFECTION
• FINDINGS IN CXR OR CT OF THE LUNGS CONSISTENT WITH INFECTION OF LOWER RESPIRATORY TRACT

Exclusion Criteria:

• AGE<18
• DENIAL TO PROVIDE INFORMED CONSENT FORM
• HISTORY OF MALIGNANCY
• PRIOR USE OF ANTICOAGULANT THERAPY
• PRIOR USE OF STEROIDS LONGER THAN 14 DAYS
• LACTATION-PREGNANCY